Healthcare Focused Fund to Invest $100 Million in Harvard Drug Development

On 3/13/19 Deerfield Management announced plans to invest $100 million in translational life science research at Harvard. Harvard University and Deerfield Management, a healthcare investment firm, have established a major strategic R&D alliance to speed the development and translation of biomedical and life-science innovations into transformative treatments that can improve life, health, and medical care. Through a newly launched company called Lab1636, Deerfield has committed $100 million in initial funding to support the alliance.